Anzeige
Mehr »
Login
Mittwoch, 24.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Business Wire-Archiv vom 07.02.2018

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
07.02.18Salt Suppliers in The Netherlands - BizVibe Announces a New B2B Networking Platform for Salt Industry in The Netherlands87BizVibe, a smart B2B networking platform for global B2B buyers and suppliers, announced today the next generation of its B2B networking platform for the top salt suppliers in the Netherlands...
► Artikel lesen
07.02.18Clarke schließt Finanzierungsrunde über 10 Mio. USD mit Saudi Aramco Energy Ventures und Chevron ab208Clarke Industrial Engineering ("Clarke") schloss heute den Verkauf von Serie B-Vorzugsaktien in Höhe von 10 Mio. USD an eine Investorengruppe unter Führung von Saudi Aramco Energy Ventures...
► Artikel lesen
07.02.18Pershing Square Holdings, Ltd. Releases Regular Weekly Net Asset Value as of 6 February 2018148Regulatory News: Pershing Square Holdings, Ltd. (LN:PSH) (NA:PSH) today released its regular weekly Net Asset Value (NAV) on its website, https://www.pershingsquareholdings.com/company-reports/weekly-navs/....
► Artikel lesen
07.02.18Purchase-to-Pay Is Considered to Be a Disruptive Trend, Says SpendEdge46SpendEdge, a global procurement intelligence advisory firm, has announced the completion of their most recent whitepaper on the seven trends reshaping purchase-to-pay. A well-executed ...
► Artikel lesen
07.02.18INVISTA's Latest P8 Technology Sees First Successful Deployment in China128INVISTA Performance Technologies (IPT) and Jiaxing Petrochemical Co., Ltd, a subsidiary of Tongkun Group Co., Ltd, announce the successful start-up of Jiaxing Petrochemical's second PTA Line...
► Artikel lesen
07.02.18Novocure Secures New $150 Million Non-Dilutive Term Loan Financing64Novocure (NASDAQ: NVCR) announced today that it has entered into a $150 million term loan agreement with BioPharma Credit PLC (LSE: BPCR), an investment fund managed by Pharmakon Advisors...
► Artikel lesen
07.02.18BitPesa Acquires TransferZero, Leading Online European Money Transfer Service133Acquisition provides deep roots to UK and European licensing, bank accounts and integrations BitPesa, the first and largest blockchain payments platform for Africa and Europe...
► Artikel lesen
07.02.18European DataWarehouse kündigt Testphase für NPL-Templates der Europäischen Bankenaufsichtsbehörde an49European DataWarehouse (ED) kündigt eine neue Initiative zur Unterstützung der Entwicklung der Märkte für notleidende Kredite (Non-Performing Loans, NPL) und der Datentemplates der Europäischen...
► Artikel lesen
07.02.18Diligent präsentiert Governance Cloud, die umfassendste heute auf dem Markt verfügbare Suite von Governance-Angeboten79Governance Cloud von Diligent befähigt Boards of Directors und Führungsteams, die komplexesten modernen Aufgabenstellungen zu bewältigen, um den Anforderungen führender Organisationen im...
► Artikel lesen
07.02.18U.S. Food and Drug Administration Approves Gilead's Biktarvy (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for Treatment of HIV-1 Infection403- In Clinical Trials, Biktarvy Demonstrated High Efficacy, Few Interactions With Other Drugs and a High Barrier to Resistance Through 48 Weeks - Gilead Sciences, Inc. (NASDAQ:GILD)...
► Artikel lesen
07.02.18HBC Provides Update on Unsolicited Offer for its German Business105HBC (TSX: HBC) today announced that, after a careful review and consideration conducted in consultation with our financial and legal advisors which included an in-person meeting with SIGNA...
► Artikel lesen
07.02.18Avast and AVG Awarded Top Rated Product by AV-Comparatives234The security solutions also received five Advanced+ awards from independent testing organization Avast, the global leader in digital security products, today announced their Avast...
► Artikel lesen
07.02.18Philippe Garin Appointed New Chief Financial Officer at Korian Group312Regulatory News: Philippe Garin has joined Korian (Paris:KORI) to take over as Group CFO from Laurent Lemaire, who, after two years dedicated to the structuring and consolidating...
► Artikel lesen
07.02.18Getlink: Concluding Step in Debt Optimisation91Regulatory News: Getlink (Paris:GET) has initiated the third and last stage of the financial reorganisation which it began in December 2015 with a further step in the optimisation...
► Artikel lesen
07.02.18BIOCORP Wins Pharmapack Award For Its New Generation Auto Injector Onejet83Regulatory News: BIOCORP (Paris:ALCOR) (FR0012788065 ALCOR Eligible PEA-PME), a French company specializing in the development and manufacturing of innovative medical and drug delivery...
► Artikel lesen
07.02.18TriLinc Global Impact Fund Makes Impact Investments in Sub-Saharan Africa, Latin America, Southeast Asia, and Emerging Europe67TriLinc Global Impact Fund announced today that it has approved an additional $27.9 million in term loans and trade finance facilities to companies operating in Sub-Saharan Africa, Latin...
► Artikel lesen
07.02.18Masimo meldet CE-Kennzeichnung für die CCHD-Screening-Anwendung für Neugeborene Eve für den Rad-97 Pulse CO-Oximeter229Masimo (NASDAQ: MASI) gibt bekannt, dass die Screening-Technologie Eve zur Untersuchung von Neugeborenen auf angeborene Herzfehler (Critical Congenital Heart Disease, CCHD) für den Rad-97...
► Artikel lesen
07.02.18Carrefour Group's Acquisition of a c17% Strategic Stake in Showroomprivé Has Been Fulfilled286Regulatory News: This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180207005885/en/ Showroomprivé, Europe's second-largest...
► Artikel lesen
07.02.18Osram Continues Growth and Increases Investments in Its Future110On a comparable basis, revenue is up by 5 percent on the prior-year quarter Company registers fifth consecutive quarter of growth Adjusted EBITDA margin remains high at around...
► Artikel lesen
07.02.18BRAF-mutiertes Melanom: Encorafenib und Binimetinib-Kombination zeigt in Phase-3-Studie (COLUMBUS) medianes Gesamtüberleben (OS) von 33,6 Monaten103Das Unternehmen Array BioPharma Inc. (Nasdaq: ARRY) und Pierre Fabre gaben erstmalig Ergebnisse der geplanten Analyse des Gesamtüberlebens (OS) aus der pivotalen Phase-3-Studie COLUMBUS bei...
► Artikel lesen
Seite:  Weiter >>